Retinal and Choroidal Changes after Anti Vascular Endothelial Growth Factor Therapy for Neovascular Age-related Macular Degeneration.
CONCLUSION: Excessive long-term vascular endothelial growth factor inhibition by an anti-vascular endothelial growth factor agent that is trapped by neuronal and retinal pigment epithelium cells may adversely affect the function of physiological vascular endothelial growth factor and harm retinal cells and vessels.
PMID: 30892159 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Kim SW, Woo JE, Yoon YS, Lee S, Woo JM, Min JK Tags: Curr Pharm Des Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Brain | Diabetes | Drugs & Pharmacology | Endocrinology | Eyes | Ganglions | Lucentis | Neurology | Ranibizumab Injection | Study | Vitamin A